alexa Oral Fluoroprimidine Based Chemotherapy of HER2 Positive Gastric Cancer | OMICS International | Abstract

Journal of Molecular Immunology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Commentary

Oral Fluoroprimidine Based Chemotherapy of HER2 Positive Gastric Cancer

Osawa H*, Shiobara H, Akashi H, Taura Y, Endo H, Ogiya K, Saeki I, Takahashi S, Shimojyu K

Department of Oncology and Hematology, Edogawa Hospital, Tokyo, Japan

*Corresponding Author:
Hiroshi Osawa
Department of Oncology and Hematology
Edogawa Hospital, 2-24-18 Higashi-Kiowa, Edogawa, Tokyo, Japan
Tel: +81-3-3673-1221
E-mail: [email protected]

Received date: August 26, 2017; Accepted date: September 06, 2017; Published date: September 13, 2017

Citation: Osawa H, Shiobara H, Akashi H, Taura Y, Endo H, et al. (2017) Oral Fluoroprimidine Based Chemotherapy of HER2 Positive Gastric Cancer. J Mol Immunol 2:113.

Copyright: © 2017 Osawa H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top